Ipamorelin + Sermorelin Side Effects: What Is Reported, Dose Signals, and What to Report

The medication this page covers:

The price is all-in: medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Compounded medications are not FDA approved.

Most side-effect pages are built from a drug label with rates against placebo. This vial has no label, because it is two compounded peptides in one vial, and the pairing has never been studied as a pairing. What exists is per component, and it is uneven.

So everything below about the blend comes from the two components' records, from what is known about growth hormone itself, and from prescribing experience. That is a legitimate basis for a physician to prescribe and monitor; it is not the same as a trial.

This group is not a list of rare dangers. It is the recognised pattern of more growth hormone than a person needs, and it is the most useful thing to understand about any growth-axis product.

Why the pairing makes these more relevant, not less

Sermorelin and ipamorelin act at two different receptors on the same pulse. A 1995 paper in Clinical Endocrinology gave eight healthy men GHRH(1-29), the sermorelin sequence, and GHRP-2, a peptide from ipamorelin's class, separately and together, and reported that the combination produced the largest growth hormone response, roughly the sum of the two. Whether this pairing behaves the same way at nightly subcutaneous doses has not been tested. But the rationale for the blend is a larger signal, and a larger signal is what produces this cluster. The live sermorelin safety page says it plainly: a larger response means the dose signals deserve more attention.

These are dose-related and described as settling when the directions are adjusted. The right response is a message to your care team on the first clear sign, not persistence and not a change you make yourself. Your physician sets your directions after reviewing your intake and how you are doing, and any new directions are printed on the vial. Numbness that does not resolve after your directions have been adjusted means the medication stops while your physician looks.

Growth hormone is counter-regulatory to insulin, so sustained increases reduce insulin sensitivity and can raise blood glucose. The secretagogue literature names this as its recurring concern, including a 2018 review in Sexual Medicine Reviews. In sermorelin's own trials it did not become a problem: fasting glucose was unchanged in the paediatric trial and in the older-adult studies. The effect is real but small at physiological levels, and larger in people whose glucose handling is already strained.

In practice: diabetes or impaired glucose tolerance is raised at intake and means closer attention rather than an automatic no, and anyone taking insulin or another glucose-lowering medication should say so. Shakiness, sweating or confusion in someone on those medications should be treated and then reported. Separately, the 16-week older-adult study of a GHRH analogue recorded a transient rise in lipids that resolved by the end of the study; that was its one adverse effect.

Growth hormone and IGF-1 are growth signals. No study has shown that sermorelin or ipamorelin causes cancer in humans, and the 2018 review states that long-term cancer-incidence data for the secretagogue class do not exist. A tissue that is already malignant can respond to growth signals, which is why active cancer is the clearest reason a physician declines any growth-axis peptide, and a history in remission is a cautious conversation taken with the oncologist's view. More is in can peptides cause cancer.

The FDA placed ipamorelin acetate in Category 2 of its interim compounding policy on 29 September 2023, citing possible immunogenicity from aggregation and impurities, the difficulty of characterising its unnatural amino acids, and serious adverse events reported with intravenous ipamorelin, while noting it lacks safety information for other injectable routes. On 29 October 2024 the Pharmacy Compounding Advisory Committee voted 0 in favour, 12 against, with one abstention, on adding it to the 503A bulks list. The FDA's safety-risks page, current as of 22 April 2026, now lists ipamorelin acetate under "bulk drug substances nominated but withdrawn," and the 503A category document updated 14 May 2026 shows it in no 503A category; it remains in Category 2 under the separate 503B policy for outsourcing facilities.

The immunogenicity concern is about how the substance is made and characterised, which is what a licensed pharmacy's sourcing and testing exist to address. Sermorelin appears in no 503A category, because it was a component of an FDA-approved drug. Neither is FDA approved as compounded here.

Never skip, double or change a dose on your own; if you miss one, follow your directions and do not take two to make up for it.

The typical directions are 0.25 mL, 25 units on a U-100 insulin syringe, delivering 0.5 mg of ipamorelin and 0.5 mg of sermorelin together. The two are in fixed 1:1 proportion, so there is no way to take more of one and less of the other. The same 25 units carry different amounts of ipamorelin in different Pepti products: 0.25 mg from the single ipamorelin vial, 0.5 mg from this one, 0.6 mg from CJC-1295 / Ipamorelin. Never carry a number over from a previous product, and never dose from a chart you found online. If your label does not match what you expected, do not inject; message your care team.

Interactions, and other medications

There is no established interaction list, because the trials that would produce one have not been run. That is why the intake asks for every medication and supplement you take and a physician reviews it rather than a form. Worth naming: anything that lowers blood glucose; glucocorticoids, which suppress growth hormone release; thyroid replacement; and testosterone, where growth hormone and testosterone have additive effects on the side-effect pattern; see can you take peptides with testosterone. Two growth-axis products from separate prescriptions should never be combined without the prescriber knowing about both.

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

The fuller per-component pages are is sermorelin safe and ipamorelin side effects. The longer-acting pairing is covered in is CJC-1295 / Ipamorelin safe.

Sermorelin has a documented safety record from its approved-drug years and small adult trials, with flushing and injection-site pain as the common effects and a transient lipid rise as the one adverse effect in the longest adult study. Ipamorelin was described as well tolerated in its two human studies, but the longest human exposure on record is seven days, by vein, and there are no human data for the subcutaneous route. The combination has never been studied. The class cautions of glucose, fluid retention and a theoretical concern about existing tumours apply until shown otherwise, and they are the basis for the questions asked at intake.

Any provider describing this blend as having no side effects, or as proven safe long term, is claiming something nobody has measured.

Ipamorelin + Sermorelin cannot be bought legitimately without a prescription. Products sold "for research use only" have no accountable pharmacy behind their identity, purity, sterility or concentration, so even the concentration your dose depends on is unknown. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and your directions printed on the vial.
5. Your care team stays reachable for side effects and questions. Refills run every 28 days, one vial per fill.

Step by step: how to get ipamorelin plus sermorelin prescribed online.